National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 7) (PB 70 of 2015) (Cth)

PB 70 of 2015

National Health Determination under paragraph 98C(1)(b) Amendment 2015
(No. 7)
_____________________________________________________________________

I, KYLIE JONASSON, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated 27 July 2015

KYLIE JONASSON
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health

1              Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2015 (No. 7).

(2)This Instrument may also be cited as PB 70 of 2015.

2              Commencement  

This instrument commences on 1 August 2015.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1            Amendments

1. Schedule 1, after entry for Phenoxymethylpenicillin with Water – Purified BP
   in the form Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL

   insert:

Valganciclovir Powder for oral solution 50 mg (as hydrochloride) per mL, 100 mL

1. Schedule 4, after entry for Glucose Indicator—Blood in the form Test strips, 100 (Accu-Chek Performa)

   insert in the column headed “Form”:

Test strips, 100 (Betachek C50)

1. Schedule 4, entry for Testosterone

   insert as first item in the column headed “Form”:

Transdermal cream 50 mg per mL, 50 mL

1. Schedule 4, after entry for Testosterone in the form Transdermal gel 50 mg
   in 5 g sachet, 30

   insert in the column headed “Form”:

Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2